The Life Sciences Web Portal for German-speaking Europe
This is a free web portal for the life sciences in German-speaking Europe... » read more
- Biocartis and VIB to Develop Colorectal Cancer Test (2013-12-06)
Biocartis and VIB announced their exclusive license agreement on a novel panel of microsatellite instability (MSI) biomarkers for several cancers, in particular colorectal cancer (CRC). This agreement will enable Biocartis to develop a unique and user-friendly assa...
- Novartis Phase 3 Study with LBH589 Meets Endpoint in MM (2013-12-06)
> Study of LBH589 plus bortezomib and dexamethasone met primary endpoint of extending PFS compared to bortezomib plus dexamethasone and placebo > LBH589 has potential to be the first in its class of anticancer agents available to patients with multiple myeloma ...
- InSphero Names Cambridge Bioscience as UK Distributor (2013-12-05)
InSphero has appointed Cambridge Bioscience as its exclusive UK distributor for 3D cell culture products and services. Cambridge Bioscience is a leading specialist distributor of life science research products in the UK, providing the very latest innovations in gen...
- Bayer CropSciences Acquires Argentinian Soybean Seeds Firm (2013-12-05)
Bayer CropScience announced today it entered into an agreement to purchase the start-up company FN Semillas S.A. based in Buenos Aires, Argentina. FN Semillas S.A. specializes in the breeding, production and marketing of improved soybean seeds in Argentina. This ac...
- Roche and Molecular Partners Enter Cancer Drug R&D Alliance (2013-12-04)
Roche (SIX: RO, ROG; OTCQX: RHHBY) and Molecular Partners AG today announced that they have entered into a research collaboration and licensing agreement to discover, develop and commercialize several proprietary therapeutics incorporating Molecular Partners' DARP...
- Monitoring Committee Recommends to End Macitentan Ph3 Study (2013-12-02)
Actelion Ltd (SIX: ATLN) announced today that following a scheduled meeting the independent Data Monitoring Committee (DMC) has recommended that the Phase III DUAL-2 study should be terminated. The DMC determined that there were no unexpected safety findings but th...
- Telormedix Raises CHF6m in Extension to Series B Round (2013-12-02)
Telormedix, a clinical stage biopharmaceutical company focused on TLR7 agonists in the treatment of cancer and inflammatory diseases, today announced that it has raised CHF 6 Million in an extension to its Series B financing from existing investors Aravis Venture (...
- bioMérieux Terminates Collaboration with Biocartis (2013-11-28)
bioMérieux, a world leader in the field of in vitro diagnostics, and Biocartis have mutually agreed to end their collaboration to develop and commercialize an integrated molecular biology system. Renouncing to its rights relating to Biocartis' technology in part...
- Bruker’s MALDI Biotyper CA System Approved by the FDA (2013-11-26)
Bruker Corporation (NASDAQ: BRKR) today announced that it has been granted U.S. FDA clearance under Section 510(k) to market its MALDI Biotyper CA System in the United States for the identification of Gram negative bacterial colonies cultured from human specimens. ...
- Gilde Healthcare Closes €145 GHC III Fund (2013-11-26)
Gilde Healthcare, the specialist investment firm, today announces the final close of its €145 million ($200 million) transatlantic growth capital fund, Gilde Healthcare III (GHC III). The new fund targets investment in innovative businesses in home and digital heal...
Life-Sciences-Germany.com is your doorway to the life sciences in German-speaking Europe!
[LSG] provides free, up-to-date and structured access to
in Germany, Austria and Switzerland.
Access is unrestricted and free, requiring no log in and no user registration.The high-quality content is not related to the advertising, with topical relevance being the criterion for inclusion. [LSG] is 100% Made in Germany!Start here with the latest News!
To subscribe to our free, monthly newsletter for the life sciences in German-speaking Europe (DE, AT & CH), please send an e-mail to firstname.lastname@example.org and simply fill the subject line with the word »LSG newsletter«
To get even more information, please take a look at our [gs] professional services offering and read the gene-sensor Product Flyer [PDF file]
Please visit also our web portals for the European life sciences and the worldwide mass spectrometry industry at Life-Sciences-Europe.com (European life sciences) and Mass-Spec-Capital.com (worldwide mass spectrometry)